Statistics for Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Total visits

views
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period 231

Total visits per month

views
December 2023 0
January 2024 1
February 2024 8
March 2024 11
April 2024 13
May 2024 11
June 2024 12

File Visits

views
Portale2019_Article_ContinuedBeneficialEffectsOfBu.pdf 329

Top country views

views
United States 155
Germany 9
Canada 6
Spain 6
Argentina 5
United Kingdom 5
Ukraine 5
Israel 4
South Korea 4
China 2
Panama 2
Sweden 2
Singapore 2
Colombia 1
France 1
Croatia 1
Malaysia 1
Serbia 1
Russia 1
Uzbekistan 1

Top city views

views
Wilmington 45
Fairfield 28
Cambridge 11
Houston 8
Baltimore 5
Jacksonville 5
Kiev 5
Tokyo 5
Buenos Aires 4
Kiez 4
Gangdong-gu 3
Jersey City 3
Madrid 3
Munich 3
San Francisco 3
Ann Arbor 2
Panama City 2
Rishon LeTsiyyon 2
Seattle 2
Singapore 2
Toronto 2
Ypsilanti 2
Barcelona 1
Be'er Ya'aqov 1
Beijing 1
Belgrade 1
Bloomfield 1
Bogotá 1
Brooklyn 1
Cartagena 1
Castelldefels 1
Cheltenham 1
Frankfurt am Main 1
Gangnam-gu 1
Kansas City 1
Killingworth 1
Lachine 1
Lake Mary 1
Landstuhl 1
Levittown 1
Lilburn 1
London 1
Milpitas 1
Montreal 1
Old Saybrook 1
Ottawa 1
Pacifica 1
Petah Tikva 1
Posadas 1
Rostov-on-Don 1
Scottsdale 1
Seremban 1
Sherbrooke 1
Södertälje 1
Tashkent 1
Tours 1
Uppsala 1
Westfield 1
Westwood 1
Yonkers 1
Zhongyuan 1